80070157 - Frontiers in Clinical Infectious Diseases

Monday, June 1, 2026, 8:00 AM - Wednesday, June 3, 2026, 5:00 PM, Johns Hopkins Bloomberg School of Public Health, Washington, DC


Infectious diseases remain a dynamic and fascinating field replete with new challenges facing outpatient primary care providers, hospital medicine practitioners, and ID specialists alike. This activity is designed to explore major infectious diseases topics of particular relevance to our target audience, which includes includes infectious diseases specialists, hospitalists, primary care physicians and midlevel providers.

1. Apply the 2024 NTCA community RIR guideline to start, continue, and discontinue TB isolation restrictions safely and efficiently.
2. Select empiric and directed regimens for priority AMR pathogens consistent with 2024 IDSA guidance, including appropriate oral stepdown and avoidance of suboptimal agents.
3. Implement updated HIV care practices, improve retention, viral suppression, and offer PrEP and doxyPEP where indicated.
4. Recognize and manage Candida auris and other fungal pathogens in varied care settings.

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.